Skip to main content

Advertisement

Fig. 5 | Stem Cell Research & Therapy

Fig. 5

From: Efficacy of mesenchymal stem cell therapy in systolic heart failure: a systematic review and meta-analysis

Fig. 5

Effect of MSCs versus placebo on 6MWT: WMD of the change of 6MWT (a), WMD of 6MWT in subgroup of donor sources (b), WMD of 6MWT in the subgroup of tissue origins (c), WMD of 6MWT in the subgroup of delivery approaches (d), WMD of 6MWT in the subgroup of preservation (e) and WMD of 6MWT in the subgroup of duration over 10 days from acquisition to injection (f)

Back to article page